Brainomix
Brainomix is an Oxford-born and successfully scaled medical imaging and data analysis company with FDA cleared, AI-powered quantitative CT imaging software (e-Lung) including unique biomarkers designed to meet the challenges of pharma, biotech and healthcare customers in clinical development and clinical practice. We support our partners through early to late stage clinical development and beyond, with our analyses providing objective, accurate and reproducible quantitative assessments of pulmonary fibrosis severity, inflammatory burden, lung volume and more.
